MediWound (MDWD) Net Income towards Common Stockholders (2013 - 2025)

MediWound's Net Income towards Common Stockholders history runs 13 years deep, the most recent figure standing at -$7.7 million for Q4 2025.

• On a quarterly basis, Net Income towards Common Stockholders fell 27.03% year-over-year to -$7.7 million in Q4 2025; TTM through Dec 2025 was -$32.7 million, a 54.34% decrease from a year earlier, with the FY2025 full-year figure at -$23.7 million, up 21.31% from the prior year.
• Net Income towards Common Stockholders slipped to -$7.7 million in Q4 2025 per MDWD's latest filing, from -$6.5 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $940000.0 in Q2 2023 and bottomed at -$13.2 million in Q2 2025.
• The 5-year median for Net Income towards Common Stockholders is -$4.2 million (2022), against an average of -$4.7 million.
• Across the five-year window, Net Income towards Common Stockholders soared 121.63% in 2023 and sank 771.17% in 2024, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$4.2 million in 2021, then plunged by 79.25% to -$7.5 million in 2022, then surged by 79.84% to -$1.5 million in 2023, then tumbled by 304.72% to -$6.1 million in 2024, then slipped by 27.03% to -$7.7 million in 2025.
• Per Business Quant, the three latest MDWD Net Income towards Common Stockholders figures stand at -$7.7 million (Q4 2025), -$6.5 million (Q3 2025), and -$13.2 million (Q2 2025).